Flu :: Canada stocking GlaxoSmithKline flu drug relenza

The Public Health Agency of Canada has signed a deal to purchase 500,000 treatment units of the flu drug Relenza to be added to the federal pandemic influenza stockpile.

The agency confirmed Friday that a deal was signed this week with GlaxoSmithKline for Relenza, an alternative to the better-known flu drug Tamiflu.

Alain Desroches, a spokesman for the agency, said the purchase is another step in achieving the goal of having 5.5 million treatment courses of flu drugs in the national antiviral stockpile.


Leave a Comment